Olubodun Tope, Ogunsola Elijah Ayowole, Coker Marcellina Olutomi, Olayinka Surajudeen Adekunle, Elegbede Waheed Àlàmú, Ojediran Joke Oluwatoyin, Olajide Kofoworola B, Sanni Salimat Bola, Oluwadare Temitope Olawumi, Inetagbo Oluwaseun Temitope, Balogun Mobolanle Rasheedat, Owolabi Onikepe Oluwadamilola, Anyadiegwu-Bello Catherine Chidimma, Runsewe Olukayode Abiodun, Temitayo-Oboh Abiola Oluwatoyin, Soyannwo Tolulope, Ogunsiji Oluwaseun Bisola, Banke-Thomas Aduragbemi
Department of Community Medicine and Primary Care, Federal Medical Center Abeokuta, Abeokuta, Ogun State, Nigeria.
Ogun State Primary Health Care Development Board, Oke-Mosan, Abeokuta, Nigeria.
Reprod Health. 2024 Dec 4;21(1):179. doi: 10.1186/s12978-024-01913-y.
Human Papillomavirus is responsible for about 5% of the global cancer burden. In Nigeria, cervical cancer is the second most common cancer among women. The Federal Government of Nigeria and partners recently introduced Human Papillomavirus (HPV) vaccination into routine immunization beginning with 15 States and the Federal Capital Territory. This study assesses HPV vaccine knowledge, attitude and program satisfaction among parents and caregivers of vaccine recipients in Ogun State, Nigeria.
This is a cross-sectional study with sample size of 1012 respondents, carried out during the 5-day HPV immunization campaign in all 20 Local Government Areas in Ogun State, Nigeria. Data was collected using interviewer-administered questionnaires. Univariate analysis was done using frequency tables and bivariate analysis using Chi-square test. Multivariate analysis was carried out to identify the determinants of knowledge of HPV, knowledge of cervical cancer and programme satisfaction.
All the respondents had heard of HPV vaccine and 67.5% had heard of cervical cancer. Eighty-two percent of the respondents heard of HPV vaccine for the first-time during the introduction programme. Eighty-two percent of respondents had good knowledge of HPV vaccine and 47.7% had good knowledge of cervical cancer. Forty-four percent of respondents heard about HPV vaccine via town/market announcers, 36.2% via radio, and 28.6% via social media. Common reasons respondents vaccinated their wards include, because there was a campaign (51.8%), to prevent cervical cancer (48.9%), and because it is free (38.3%). Twenty-nine percent were very satisfied with the HPV vaccination program and 63.2% were satisfied. All the respondents had positive attitude towards HPV vaccination, although 94.1% had heard messages discouraging people from vaccinating their wards. Respondents living in rural communities had higher odds of having good knowledge of HPV vaccine (aOR 2.232, 95% CI 1.527-3.263, p-value ≤ 0.001). Fathers with tertiary education were more likely to be satisfied with the programme (aOR 5.715, 95% CI 1.142-28.589, p-value = 0.034), CONCLUSION: Knowledge of HPV vaccination was high and was informed by the HPV vaccination introduction programme. Use of outreaches, awareness drives, and provision of free vaccines should be intensified to further promote HPV vaccine uptake in Nigeria.
人乳头瘤病毒（HPV）导致了全球约5%的癌症负担。在尼日利亚，宫颈癌是女性中第二常见的癌症。尼日利亚联邦政府及其合作伙伴最近将人乳头瘤病毒（HPV）疫苗接种引入常规免疫，首先从15个州和联邦首都地区开始。本研究评估了尼日利亚奥贡州HPV疫苗接种接受者的父母和照料者对HPV疫苗的知识、态度及对该项目的满意度。
这是一项横断面研究，样本量为1012名受访者，在尼日利亚奥贡州所有20个地方政府辖区举行为期5天的HPV免疫接种活动期间开展。数据通过访谈员管理的问卷收集。单变量分析使用频率表进行，双变量分析使用卡方检验。进行多变量分析以确定HPV知识、宫颈癌知识及项目满意度的决定因素。
所有受访者都听说过HPV疫苗，67.5%听说过宫颈癌。82%的受访者在引入项目期间首次听说HPV疫苗。82%的受访者对HPV疫苗有良好的了解，47.7%对宫颈癌有良好的了解。44%的受访者通过城镇/市场广播员听说过HPV疫苗，36.2%通过广播，28.6%通过社交媒体。受访者为其子女接种疫苗的常见原因包括，因为有宣传活动（51.8%）、预防宫颈癌（48.9%）以及因为免费（38.3%）。29%的人对HPV疫苗接种项目非常满意，63.2%的人满意。所有受访者对HPV疫苗接种持积极态度，尽管94.1%的人听过劝阻人们为其子女接种疫苗的信息。居住在农村社区的受访者对HPV疫苗有良好了解的几率更高（调整后比值比2.232，95%置信区间1.527 - 3.263，p值≤0.001）。受过高等教育的父亲对该项目更有可能满意（调整后比值比5.715，95%置信区间1.142 - 28.589，p值 = 0.034）。结论：HPV疫苗接种知识水平较高，这得益于HPV疫苗接种引入项目。应加强外展活动、提高认识宣传及免费疫苗的提供，以进一步促进尼日利亚的HPV疫苗接种率。
